Neuroblastoma and Other Childhood Neural Tumors: A Review

References

• Beckwith J B, Perrin E V. In situ neuroblastomas: A contribution to the natural history of neural crest tumors. Am J Pathol 1963; 43: 1089–104
   PubMed Web of Science ®Google Scholar
• Laug W E, Siegel S E, Shaw K N, Landing B, Baptista J, Gutenstein M. Initial urinary catecholamine metabolite concentrations and prognosis in neuroblastoma. Pediatrics 1978; 62: 77–83
   PubMed Web of Science ®Google Scholar
• Seeger R C, Brodeur G M, Sather H, et al. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 1985; 313: 1111–6
   PubMed Web of Science ®Google Scholar
• Brodeur G M, Seeger R C, Sather H, et al. Clinical implications of oncogene activation in human neuroblastomas. Cancer 1986; 58(suppl 2)541–5
   PubMedGoogle Scholar
• Brodeur G M, Seeger R C. Gene amplification in human neuroblastomas: Basic mechanisms and clinical implications. Cancer Genet Cytogenet 1986; 19: 101–11
   PubMedGoogle Scholar
• Triche T J, Cavazzana A O. Pathology in pediatric oncology. Principles and Practice of Pediatric Oncology, P A Pizzo, D G Poplack. JB Lippincott, Philadelphia 1989; 93–125
   Google Scholar
• Dehner L P. Peripheral and central primitive neuroectodermal tumors: A nosologic concept seeking a consensus. Arch Pathol Lab Med 1986; 110: 997–1005
   PubMed Web of Science ®Google Scholar
• Aleshire S L, Glick A D, Cruz V E, Bradley C A, Parl F F. Neuroblastoma in adults. Pathologic findings and clinical outcome. Arch Pathol Lab Med 1985; 109: 352–6
   PubMed Web of Science ®Google Scholar
• Behr A, Uijs R R, Phillips J I. Neuroblastoma in adults. A report of 3 cases. S Afr Med J 1989; 75: 333–5
   PubMed Web of Science ®Google Scholar
• Dehner L P. Will the “real” neuroblastoma please stand up? (Letter). Arch Pathol Lab Med 1985; 109: 794–5
   PubMedGoogle Scholar
• Gohji K, Nakanishi T, Hara I, Hamami G, Kamidono S. Two cases of primary neuroblastoma of the kidney in adults. J Urol 1987; 137: 966–8
   PubMed Web of Science ®Google Scholar
• Kaye J A, Warhol M J, Kretschmar C, Landsberg L, Frei E, 3d. Neuroblastoma in adults. Three case reports and a review of the literature. Cancer 1986; 58: 1149–57
   PubMed Web of Science ®Google Scholar
• Mackay B, Luna M A, Butler J J. Adult neuroblastoma. Electron microscopic observations in nine cases. Cancer 1976; 37: 1334–51
   PubMed Web of Science ®Google Scholar
• Allan S G, Cornbleet M A, Carmichael J, Arnott S J, Smyth J F. Adult neuroblastoma. Report of three cases and review of the literature. Cancer 1986; 24: 19–21
   Google Scholar
• Choi H S, Anderson P J. Olfactory neuroblastoma: An immuno-electron microscopic study of S-100 protein-positive cells. J Neuropathol Exp Neurol 1986; 45: 576–87
   PubMedGoogle Scholar
• Micheau C. A new histochemical and biochemical approach to olfactory esthesioneuroblastoma. A nasal tumor of neural crest origin. Cancer 1977; 40: 314–8
   PubMedGoogle Scholar
• Kadish S, Goodman M, Wang C C. Olfactory neuroblastoma. A clinical analysis of 17 cases. Cancer 1976; 37: 1571–6
   PubMed Web of Science ®Google Scholar
• Mills E M, Frierson H F, Jr. Olfactory neuroblastoma. A clinicopathologic study of 21 cases. Am J Surg Pathol 1985; 9: 317–27
   PubMed Web of Science ®Google Scholar
• Hirano T, Aida T, Moriyama M, Asano G, Suzuki I, Yuge K. Primary neuroblastoma of the nasal cavity and review of literature. Acta Pathol Jpn 1985; 35: 183–91
   PubMedGoogle Scholar
• Machin G A. Histogenesis and histopathology of neuroblastoma. Neuroblastoma: Clinical and Biological Manifestations, C Pochedly. Elsevier Biomedical, New York 1982; 194–231
   Google Scholar
• Richards M J S, Joo P, Gilbert E F. The rare problem of late recurrence in neuroblastoma. Cancer 1976; 38: 1847–62
   PubMedGoogle Scholar
• Bolande R P. Spontaneous regression and cytodifferentiation of cancer in early life: The oncogenic grace period. Surv Synth Pathol Res 1985; 4: 296–311
   PubMedGoogle Scholar
• Mir R, Phillips S L, Schwartz G, Mathur R, Khan A, Kahn L B. Metastatic neuroblastoma after 52 years of dormancy. Cancer 1987; 60: 2510–4
   PubMedGoogle Scholar
• Haas D, Ablin A R, Miller C, Zoger S, Matthay K K. Complete pathologic maturation and regression of stage IVS neuroblastoma without treatment. Cancer 1988; 62: 818–25
   PubMedGoogle Scholar
• Mackay B, Ordonez N G. Adult neuroblastoma of bone: A case report. Ultrastruct Pathol 1987; 11: 455–64
   PubMed Web of Science ®Google Scholar
• Lanford J A, Cohn I. Ependymal neoplasm of the median nerve: With case report. South Med J 1927; 20: 273–5
   Google Scholar
• Penfield W. Tumors of the sheaths of the nervous system: Cytology and cellular pathology of the nervous system. Paul B Hoeber, New York 1932; 980
   Google Scholar
• Stout A P, Murray M R. Neuroepithelioma of the radial nerve with a study of its behavior in vitro. Rev Can Biol 1942; 1: 651–9
   Google Scholar
• Nesbitt K A, Vidone R A. Primitive neuroectodermal tumor (neuroblastoma) arising in the sciatic nerve of a child. Cancer 1976; 37: 1562–70
   PubMed Web of Science ®Google Scholar
• Flexner S. A peculiar glioma (neuroepithelioma?) of the retina. Johns Hopkins Hosp Bull 1891; 2: 115
   Google Scholar
• Bolen J W, Thorning D. Peripheral neuroepithelioma: A light and electron microscopic study. Cancer 1980; 46: 2456–62
   PubMed Web of Science ®Google Scholar
• Voss B L, Pysher T J, Humphrey G B. Peripheral neuroepithelioma in childhood. Cancer 1984; 54: 3059–64
   PubMed Web of Science ®Google Scholar
• Schmidt D, Mackay B, Ayala A G. Ewing's sarcoma with neuroblastoma-like features. Ultrastruct Pathol 1982; 3: 143–51
   PubMed Web of Science ®Google Scholar
• Jaffe R, Santamaria M, Yunis E J, et al. The neuroectodermal tumor of bone. Am J Surg Pathol 1984; 8: 885–98
   PubMed Web of Science ®Google Scholar
• Perez-Atayde A R, Grier H, Weinstein H, Delorey M, Leslie N, Vawter G. Neuroectodermal differentiation in bone tumors presenting as Ewing's sarcoma. SIOP, XVIIIth meeting, VeniceItaly, 1985; 61
   Google Scholar
• Haas O A, Chott A, Ladenstein R, Gadner H. Poorly differentiated, neuron-specific enolase positive round cell tumor with two translocations t(11;22) and t(21;22). Cancer 1987; 60: 2219–23
   PubMedGoogle Scholar
• Llombart-Bosch A, Lacombe M J, Contesso G, Peydro-Olaya A. Small round blue cell sarcoma of bone mimicking atypical Ewing's sarcoma with neuroectodermal features. An analysis of five cases with immunohistochemical and electron microscopic support. Cancer 1987; 60: 1570–82
   PubMed Web of Science ®Google Scholar
• Llombart-Bosch A, Lacombe M J, Peydro-Olaya A, Perez-Bacete M, Contesso G. Malignant peripheral neuroectodermal tumours of bone other than Askin's neoplasm: Characterization of 14 new cases with immunohistochemistry and electron microscopy. Virchows Aarch ‘A’ 1988; 412: 421–30
   Google Scholar
• Seemayer T A, Thelmo W I, Bolande R P, Wiglesworth F W. Peripheral neuroectodermal tumors. Perspect Pediatr Pathol 1975; 2: 151–65
   PubMedGoogle Scholar
• Harper P G, Pringle J, Souhami R I. Neuroepithelioma—a rare malignant peripheral nerve tumor of primitive origin: Report of two new cases and a review of the literature. Cancer 1981; 48: 2282–7
   PubMed Web of Science ®Google Scholar
• Hashimoto H, Enjoji M, Nakajima T, Kiryu H, Daimaru Y. Malignant neuroepithelioma (peripheral neuroblastoma): A clinicopathologic study of 15 cases. Am J Surg Pathol 1983; 7: 309–18
   PubMed Web of Science ®Google Scholar
• Schmidt D, Harms D, Burdach S. Malignant peripheral neuroectodermal tumours of childhood and adolescence. Virchows Arch ‘A’ 1985; 406: 351–65
   Web of Science ®Google Scholar
• Argenyi Z B, Bergfeld W F, McMahon J T, Goeken J A, Garewal G S. Primitive neuroectodermal tumor in the skin with features of neuroblastoma in an adult patient. J Cutan Pathol 1986; 13: 420–30
   PubMedGoogle Scholar
• Jurgens H, Bier V, Harms D, Beck J, et al. Malignant peripheral neuroectodermal tumors. A retrospective analysis of 42 patients. Cancer 1988; 61: 349–57
   PubMedGoogle Scholar
• Askin F B, Rosai J, Sibley R K, Dehner L P, McAlister W H. Malignant small cell tumor of the thoracopulmonary region in childhood: A distinctive clinicopathologic entity of uncertain histogenesis. Cancer 1979; 43: 2438–51
   PubMed Web of Science ®Google Scholar
• Linnoila R I, Tsokos M, Triche T J, Marangos P J, Chandra R S. Evidence for neural origin and PAS-positive variants of the malignant small cell tumor of thoracopulmonary region (“Askin tumor”). Am J Surg Pathol 1986; 10: 124–33
   PubMed Web of Science ®Google Scholar
• Gonzalez-Crussi F, Wolfson S L, Misugi K, Nakajima T. Peripheral neuroectodermal tumors of the chest wall in childhood. Cancer 1984; 54: 2519–27
   PubMedGoogle Scholar
• Miller R W, Dalager B S. U.S. childhood cancer deaths by cell type, 1960–68. J Pediatr 1974; 85: 664–8
   PubMed Web of Science ®Google Scholar
• Myers M H, Heise H W, Li F P, Miller R W. Trends in cancer survival among U.S. white children, 1955–1971. J Pediatr 1975; 87: 815–8
   PubMedGoogle Scholar
• Young J L, Jr, Miller R W. Incidence of malignant tumors in U.S. children. J Pediatr 1975; 86: 254–8
   PubMed Web of Science ®Google Scholar
• Davis S, Rogers M A, Pendergrass T W. The incidence and epidemiologic characteristics of neuroblastoma in the United States. Am J Epidemiol 1987; 126: 1063–74
   PubMed Web of Science ®Google Scholar
• Harms D, Schmidt D, Treuner J. Soft tissue sarcomas in childhood. A study of 262 cases including 169 cases of rhabdomyosarcoma. Z Kinderchir 1985; 40: 140–5
   PubMedGoogle Scholar
• Harms D, Schmidt D. Classification of solid tumors in children—the Kiel Pediatric Tumor Registry. Monogr Paediatr 1986; 18: 1–18
   Google Scholar
• Harms D. Cooperative studies on childhood tumors in Germany: First course on the pathology of pediatric tumors. Istituto “Giannina Gaslini,” International School of Pediatric Sciences, GenoaItaly 1987
   Google Scholar
• Mason G A, Hart-Mercer J, Miller E J, et al. Adrenaline-secreting neuroblastoma in an infant. Lancet 1957; 2: 322–5
   Google Scholar
• LaBrosse E H, Comoy E, Bohoun C, Zucker J M, Schweisguth O. Catecholamine metabolism in neuroblastoma. J Natl Cancer Inst 1976; 57: 633–8
   PubMed Web of Science ®Google Scholar
• Brewster M A, Berry D A. Serial studies of serum dopamine-B-hydroxylase and urinary vanillylmandelic and homovanillic acids in neuroblastoma. Med Pediatr Oncol 1979; 6: 93–9
   PubMedGoogle Scholar
• Maurus R, Otten J. Biologic markers in neuroblastoma. Recent results. Cancer Res 1979; 67: 78–84
   Google Scholar
• LaBrosse E H, Com-Nougue C, Zucker J M, et al. Urinary excretion of 3–methoxy-4–hydroxymandelic acid and 3–methoxy-4–hydroxyphenylacetic acid by 288 patients with neuroblastoma and related neural crest tumors. Cancer Res 1980; 40: 1995–2001
   PubMed Web of Science ®Google Scholar
• Ross R A, Biedler J L, Spengler B A, Reis D J. Neurotransmitter-synthesizing enzymes in 14 human neuroblastoma cell lines. Cell Mol Neurobiol 1981; 3: 301–11
   Google Scholar
• Reynolds C P, Biedler J L, Spengler B A, et al. Characterization of human neuroblastoma cell lines established before and after therapy. J Natl Cancer Inst 1986; 76: 375–87
   PubMedGoogle Scholar
• Tsokos M, Scarpa S, Ross R A, Triche T J. Differentiation of human neuroblastoma recapitulates neural crest development. Study of morphology, neurotransmitter enzymes, and extracellular matrix proteins. Am J Pathol 1987; 128: 484–96
   PubMed Web of Science ®Google Scholar
• Thiele C J, McKeon C, Triche T J, Ross R A, Reynolds C P, Israel M A. Differential protooncogene expression characterizes histopathologically indistinguishable tumors of the peripheral nervous system. J Clin Invest 1987; 80: 804–11
   PubMed Web of Science ®Google Scholar
• Biedler J L, Spengler B A, Chang T D, Ross R A. Transdifferentiation of human neuroblastoma cells results in coordinate loss of neuronal and malignant properties. Prog Clin Biol Res 1988; 271: 265–76
   PubMedGoogle Scholar
• Ciccarone V, Spengler B A, Meyers M B, Biedler J L, Ross R A. Phenotypic diversification in human neuroblastoma cells: Expression of distinct neural crest lineages. Cancer Res 1989; 49: 219–25
   PubMed Web of Science ®Google Scholar
• Cavazzana A O, Magnani J L, Ross R A, Miser J, Triche T J. Ewing's sarcoma is an undifferentiated neuroectodermal tumor. Prog Clin Biol Res 1988; 271: 487–98
   PubMedGoogle Scholar
• Montgomery K T, Biedler J L, Spengler B A, Melera P W. Specific DNA sequence amplification in human neuroblastoma cells. Proc Natl Acad Sci USA 1983; 80: 5724–8
   PubMedGoogle Scholar
• Biedler J L, Meyers M B, Spengler B A. Homogeneously staining regions and double minute chromosomes: Prevalent cytogenetic abnormalities of human neuroblastoma cells. Adv Cell Neurobiol 1983; 4: 267–307
   Google Scholar
• Gilbert F, Feder M, Balaban G, et al. Human neuroblastomas and abnormalities of chromosomes 1 and 17. Cancer Res 1984; 44: 5444–9
   PubMed Web of Science ®Google Scholar
• Christiansen H, Lampert F. Tumour karyotype discriminates between good and bad prognostic outcome in neuroblastoma. Br J Cancer 1988; 57: 121–6
   PubMed Web of Science ®Google Scholar
• Schwab M, Varmus H E, Bishop J M, et al. Chromosome localization in normal human cells and neuroblastomas of a gene related to c-myc. Nature 1984; 308: 288–91
   PubMed Web of Science ®Google Scholar
• Brodeur G M, Fong C T, Morita M, Griffith R, Hayes F A, Seeger R C. Molecular analysis and clinical significance of N-myc amplification and chromosome 1p monosomy in human neuroblastomas. Prog Clin Biol Res 1988; 271: 3–15
   PubMedGoogle Scholar
• Shiloh Y, Korf B, Kohl N E, et al. Amplification and rearrangement of DNA sequences from the chromosomal region 2p24 in human neuroblastoma. Cancer Res 1986; 46: 5297–301
   PubMedGoogle Scholar
• Brodeur G M, Seeger R C, Schwab M, Varmus H E, Bishop J M. Amplification of N-myc sequences in primary human neuroblastomas: Correlation with advanced disease stage. Prog Clin Biol Res 1985; 175: 105–13
   PubMedGoogle Scholar
• Franke F, Rudolph B, Christiansen H, Harbott J, Lampert F. Tumour karyotype may be important in the prognosis of human neuroblastoma. J Cancer Res Clin Oncol 1986; 111: 266–72
   PubMedGoogle Scholar
• Hayashi Y, Hanada R, Yamamoto K, Bessho F. Chromosome findings and prognosis in neuroblastoma. (Letter). Cancer Genet Cytogenet 1987; 29: 175–7
   PubMedGoogle Scholar
• Hayashi Y, Inaba T, Hanada R, Yamamoto K. Chromosome findings and prognosis in 15 patients with neuroblastoma found by VMA mass screening. J Pediatr 1988; 112: 567–71
   PubMedGoogle Scholar
• Thiele C J, Reynolds C P, Israel M A. Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma. Nature 1985; 313: 404–6
   PubMed Web of Science ®Google Scholar
• Rosen N, Reynolds C P, Thiele C J, Biedler J L, Israel M A. Increased N-myc expression following progressive growth of human neuroblastoma. Cancer Res 1986; 46: 4139–42
   PubMed Web of Science ®Google Scholar
• Brodeur G M, Seeger R C, Schwab M, Varmus H E, Bishop J M. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 1984; 224: 1121–4
   PubMed Web of Science ®Google Scholar
• Tonini G P, Verdona G, DeBernardi B, Sansone R, Massimo L, Cornaglia-Ferraris P. N-myc oncogene amplification in a patient with IV-S neuroblastoma. Am J Pediatr Hematol Oncol 1987; 9: 8–10
   PubMedGoogle Scholar
• Thiele C J, Deutsch L A, Israel M A. The expression of multiple proto-oncogenes is differentially regulated during retinoic acid induced maturation of human neuroblastoma cell lines. Oncogene 1988; 3: 281–8
   PubMed Web of Science ®Google Scholar
• Cavazzana A O, Navarro S, Noguera R, Reynolds P C, Triche T J. Olfactory neuroblastoma is not a neuroblastoma but is related to primitive neuroectodermal tumor (PNET). Prog Clin Biol Res 1988; 271: 463–73
   PubMedGoogle Scholar
• Seeger R C, Wada R, Brodeur G M, et al. Expression of N-myc by neuroblastomas with one or multiple copies of the oncogene. Prog Clin Biol Res 1988; 271: 41–9
   PubMedGoogle Scholar
• Reynolds C P, Tomayko M M, Donner L, et al. Biological classification of cell lines derived from human extra-cranial neural tumors. Prog Clin Biol Res 1988; 271: 291–306
   PubMedGoogle Scholar
• Ramsay G, Stanton L, Schwab M, Bishop J M. Human proto-oncogene N-myc encodes nuclear proteins that bind DNA. Mol Cell Biol 1986; 6: 4450–67
   PubMedGoogle Scholar
• Slamon D J, Boone T C, Seeger R C, et al. Identification and characterization of the protein encoded by the human N-myc oncogene. Science 1986; 232: 768–72
   PubMedGoogle Scholar
• Ikegaki N, Bukovsky J, Kennett R H. Identification and characterization of the NMYC gene product in human neuroblastoma cells by monoclonal antibodies with defined specificities. Proc Natl Acad Sci USA 1986; 83: 5929–33
   PubMedGoogle Scholar
• Ikegaki N, Polakova K, Prince L, Kennett R H. Expression and localization of the N-myc protein in human neuroblastoma cells: Analysis of the effect of gamma interferon treatment and distribution of the N-myc protein in the nucleus. Prog Clin Biol Res 1988; 271: 133–44
   PubMedGoogle Scholar
• Moss T J, Law Y M, Slamon D J, Brodeur G M, Seeger R C. N-myc protein expression by neuroblastoma cells that have metastasized to bone marrow. Prog Clin Biol Res 1988; 271: 91–101
   PubMedGoogle Scholar
• Triche T J, Cavazzana A O, Navarro S, Reynolds C P, Slamon D J, Seeger R E. N-myc protein expression in small round cell tumors. Prog Clin Biol Res 1988; 271: 475–85
   PubMedGoogle Scholar
• Cohen P S, Seeger R C, Triche T J, Israel M A. Detection of N-myc gene expression in neuroblastoma tumors by in situ hybridization. Am J Pathol 1988; 131: 391–7
   PubMed Web of Science ®Google Scholar
• Seeger R C, Siegel S E, Sidell N. Neuroblastoma: Clinical perspectives, monoclonal antibodies, and retinoic acid. Ann Intern Med 1982; 97: 873–84
   PubMed Web of Science ®Google Scholar
• Wilson B S, Lloyd R V. Detection of chromogranin in neuroendocrine cells with a monoclonal antibody. Am J Pathol 1984; 115: 458–68
   PubMed Web of Science ®Google Scholar
• Sugimoto T, Tatsumi E, Kemshead J T, Helson L, Green A A, Minowada J. Determination of cell surface membrane antigens common to both human neuroblastoma and leukemia-lymphoma cell lines by a panel of 38 monoclonal antibodies. J Natl Cancer Inst 1984; 73: 51–7
   PubMed Web of Science ®Google Scholar
• Vincent M, Thiery J P. A cell surface marker for neural crest and placodal cells: Further evolution in peripheral and central nervous system. Dev Biol 1984; 103: 468–81
   PubMedGoogle Scholar
• Donner L, Triche T J, Israel M A, Seeger R C, Reynolds C P. A panel of monoclonal antibodies which discriminate neuroblastoma from Ewing's sarcoma, rhabdomyosarcoma, neuroepithelioma and hematopoietic malignancies. Prog Clin Biol Res 1985; 175: 347–66
   PubMedGoogle Scholar
• Cheung N K, Saarinen U M, Neely J E, Landmeier B, Donovan D, Coccia P F. Monoclonal antibodies to a glycolipid antigen on human neuroblastoma cells. Cancer Res 1985; 45: 2642–9
   PubMed Web of Science ®Google Scholar
• Schonmann S M, Iyer J, Laeng H, Gerber H A, Kaser H, Blaser K. Production and characterization of monoclonal antibodies against human neuroblastoma. Int J Cancer 1986; 37: 255–62
   PubMedGoogle Scholar
• Gross N, Beck D, Carrel S, Munoz M. Highly selective recognition of human neuroblastoma cells by mouse monoclonal antibody to a cytoplasmic antigen. Cancer Res 1986; 46: 2988–94
   PubMedGoogle Scholar
• Wu Z L, Schwartz E, Seeger R, Ladisch S. Expression of GD2 ganglioside by untreated primary human neuroblastomas. Cancer Res 1986; 46: 440–3
   PubMed Web of Science ®Google Scholar
• Smith R G, Reynolds C P. Monoclonal antibody recognizing a human neuroblastoma-associated antigen. Diagn Clin Immunol 1987; 5: 209–20
   PubMedGoogle Scholar
• Lipinski M, Hirsch M R, Deagostini-Bazin H, Yamada O, Tursz T, Goridis C. Characterization of neural cell adhesion molecules (NCAM) expressed by Ewing and neuroblastoma cell lines. Int J Cancer 1987; 40: 81–6
   PubMed Web of Science ®Google Scholar
• McGarry R C, Pinto A, Hammersley-Straw D R, Trevenen C L. Expression of markers shared between human natural killer cells and neuroblastoma lines. Cancer Immunol Immunother 1988; 27: 47–52
   PubMedGoogle Scholar
• Sugimoto T, Sawada T, Matsumura T, et al. Diagnosis of neuroblastoma metastasis in bone marrow with a panel of monoclonal antibodies. Med Pediatr Oncol 1988; 16: 190–6
   PubMedGoogle Scholar
• Wick M R, Stanley S J, Swanson P E. Immunohistochemical diagnosis of sinonasal melanoma, carcinoma, and neuroblastoma with monoclonal antibodies HMB-45 and antisynaptophysin. Arch Pathol Lab Med 1988; 112: 616–20
   PubMed Web of Science ®Google Scholar
• Allan P M, Garson J A, Harper El, et al. Biological characterization and clinical applications of a monoclonal antibody recognizing an antigen restricted to neuroectodermal tissues. Int J Cancer 1983; 31: 591–8
   PubMedGoogle Scholar
• Oppedal B R, Brandtzaeg P, Kemshead J T. Immunohistochemical differentiation of neuroblastomas from other small round cell neoplasms of childhood using a panel of mono-and polyclonal antibodies. Histopathology 1987; 11: 363–74
   PubMed Web of Science ®Google Scholar
• Gibson F M, Kemshead J T. A monoclonal antibody (FMG25) that can differentiate neuroblastoma from other small round-cell tumours of childhood. Int J Cancer 1987; 39: 554–9
   PubMedGoogle Scholar
• Kemshead J T. Monoclonal antibodies to the small round cell tumours of childhood: An international workshop. Prog Clin Biol Res 1988; 271: 535–46
   PubMedGoogle Scholar
• Matsumura T, Sugimoto T, Sawada T, Saida T, Kemshead J T. Distinctive membrane phenotypes of neuroblastoma cells and fetal neuroblasts by a panel of monoclonal antibodies. Prog Clin Biol Res 1988; 271: 395–407
   PubMedGoogle Scholar
• Carey P J, Malcolm A J, Pearson A D, Kemshead J T, Reid M M. Immunocytochemical detection of tumours of neuroectodermal origin ‘published erratum appears in. J Clin Pathol 1988; 41: 924, J Clin Pathol 1988, 41: 586–9
   Google Scholar
• Kemshead J T, Clayton J, Patel K. Monoclonal antibodies used for the diagnosis of the small round cell tumors of childhood. Pediatric Tumors: Immunological and Molecular Markers, J T Kemshead. CRC Press, Boca Raton, Fla 1989; 31–45
   Google Scholar
• Lampson L A. Biological significance of HLA-A, B, C expression in neuroblastoma and related cell lines. Prog Clin Biol Res 1988; 271: 409–20
   PubMedGoogle Scholar
• Funa K, Gazdar A F, Minna J D, Linnoila R I. Paucity of β2-microglobulin expression on small cell lung cancer, bronchial carcinoids, and certain other neuroendocrine tumors. Lab Invest 1986; 55: 186–93
   PubMedGoogle Scholar
• Bernards R, Dessain S K, Weinberg R A. N-myc amplification causes down-modulation of MHC class I antigen expression in neuroblastoma. Cell 1986; 47: 667–74
   PubMed Web of Science ®Google Scholar
• Triche T J. Diagnosis of small round cell tumors of childhood. Bull Cancer (Paris) 1988; 75: 297–310
   PubMedGoogle Scholar
• Ehrhart M, Grube D, Bader M F, Aunis D, Gratzl M. Chromogranin A in the pancreatic islet: Cellular and subcellular distribution. J Histochem Cytochem 1986; 34: 1673–82
   PubMed Web of Science ®Google Scholar
• Angelleti R H. Chromogranins and neuroendocrine secretion. Lab Invest 1986; 55: 387–90
   PubMedGoogle Scholar
• Schmidt W E, Siegel E G, Kratzin H, Creutzfeldt W. Isolation and primary structure of tumor-derived peptides related to human pancreastatin and chromogranin A. Proc Natl Acad Sci USA 1988; 85: 8231–5
   PubMed Web of Science ®Google Scholar
• Wiedenmann B, Franke W W, Kuhn C, Moll R, Gould V E. Synaptophysin: A marker protein for neuroendocrine cells and neoplasms. Proc Natl Acad Sci USA 1986; 83: 3500–4
   PubMed Web of Science ®Google Scholar
• Gould V E. Synaptophysin. A new and promising pan-neuroendocrine marker. Arch Pathol Lab Med 1987; 111: 791–4
   PubMedGoogle Scholar
• Widenmann B, Kuhn C, Schwechheimer K, et al. Synaptophysin identified in metastases of neuroendocrine tumors by immunocytochemistry and immunoblotting. Am J Clin Pathol 1987; 88: 560–9
   PubMedGoogle Scholar
• Pietsch T, Gottert E, Meese E, et al. Characterization of a continuous cell line (MHH-NB-11) derived from advanced neuroblastoma. Anticancer Res 1988; 8: 1329–33
   PubMed Web of Science ®Google Scholar
• Oppedal B R, Storm M I, Lie S O, Brandtzaeg P. Prognostic factors in neuroblastoma. Clinical, histopathologic, and immunohistochemical features and DNA ploidy in relation to prognosis. Cancer 1988; 62: 772–80
   PubMed Web of Science ®Google Scholar
• Brook F B, Raafat F, Eldeeb B B, Mann J R. Histologic and immunohistochemical investigation of neuroblastomas and correlation with prognosis. Hum Pathol 1988; 19: 879–88
   PubMed Web of Science ®Google Scholar
• Dhillon A P, Rode J, Leathem A. Neurone specific enolase: An aid to the diagnosis of melanoma and neuroblastoma. Histopathology 1982; 6: 81–92
   PubMed Web of Science ®Google Scholar
• Osborn M, Dirk T, Kaser H, Weber K, Altmannsberger M. Immunohistochemical localization of neurofilaments and neuron-specific enolase in 29 cases of neuroblastoma. Am J Pathol 1986; 122: 433–42
   PubMed Web of Science ®Google Scholar
• Tsokos M, Linnoila R I, Chandra R S, Triche T J. Neuron-specific enolase in the diagnosis of neuroblastoma and other small, round-cell tumors in children. Hum Pathol 1984; 15: 575–84
   PubMed Web of Science ®Google Scholar
• Viallard J L, Tiget F, Hartmann O, et al. Serum neuron-specific/nonneuronal enolase ratio in the diagnosis of neuroblastomas. Cancer 1988; 62: 2546–53
   PubMed Web of Science ®Google Scholar
• Hachitanda Y, Tsuneyoshi M, Enjoji M. Expression of pan-neuroendocrine proteins in 53 neuroblastic tumors. An immunohistochemical study with neuron-specific enolase, chromogranin, and synaptophysin. Arch Pathol Lab Med 1989; 113: 381–4
   PubMedGoogle Scholar
• Dranoff G, Bigner D D. A word of caution to the use of neuron-specific enolase expression in tumor diagnosis. (Editorial). Arch Pathol Lab Med 1984; 108: 535
   PubMed Web of Science ®Google Scholar
• Schmechel D E. Gamma-subunit in the glycolytic enzyme enolase: Nonspecific or neuron specific?. Lab Invest 1985; 52: 239–42
   PubMed Web of Science ®Google Scholar
• Haimoto H, Takahashi Y, Koshikawa T, Nagura H, Kato K. Immunohistochemical localization of gamma-enolase in normal human tissues other than nervous and neuroendocrine tissues. Lab Invest 1985; 52: 257–63
   PubMed Web of Science ®Google Scholar
• Pahlman S, Esscher T, Nilsson K. Expression of gamma-subunit of enolase, neuron-specific enolase, in human non-neuroendocrine tumors and derived cell lines. Lab Invest 1986; 54: 554–60
   PubMed Web of Science ®Google Scholar
• Chatten J, Shimada H, Sather H N, Wong K Y, Siegel S E, Hammond G D. Prognostic value of histopathology in advanced neuroblastoma: A report from the Children's Cancer Study Group. Hum Pathol 1988; 19: 1187–98
   PubMed Web of Science ®Google Scholar
• Shimada H, Chatten J, Newton W A, et al. Histopathologic prognostic factors in neuroblastic tumors: Definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst 1984; 73: 406–16
   Google Scholar
• Triche T J, Askin F B. Neuroblastoma and the differential diagnosis of small-, round-, blue-cell tumors. Hum Pathol 1983; 14: 569–95
   PubMed Web of Science ®Google Scholar
• Triche T J. Neuroblastoma—biology confronts nosology. (Editorial). Arch Pathol Lab Med 1986; 110: 994–6
   PubMedGoogle Scholar
• Le Douarin N. Migration and differentiation of neural crest cells. Curr Top Dev Biol 1980; 16: 31–85
   PubMedGoogle Scholar
• Anderson D J, Axel R. Molecular probes for the development and plasticity of neural crest derivatives. Cell 1985; 42: 649–62
   PubMed Web of Science ®Google Scholar
• Heideman R L, Packer R J, Albright L A, Freeman C R, Rorke L B. Tumors of the central nervous system. Principles and Practice of Pediatric Oncology, P A Pizzo, D G Poplack. JB Lippincott, Philadelphia 1988; 506–53
   Google Scholar
• Micheau C, Guerinot F, Bohuon C, Brugere J. Dopamine-β–hydroxylase and catecholamines in an olfactory esthesioneuroma. Cancer 1975; 35: 1309–12
   PubMedGoogle Scholar
• Miller D C, Goodman M L, Pilch B Z, et al. Mixed olfactory neuroblastoma and carcinoma. A report of two cases. Cancer 1984; 54: 2019–28
   PubMedGoogle Scholar
• Cullen M J, Cusack D A, O'Briain D S, Devlin J B, Kehely A, Lyons T A. Neurosecretion of arginine vasopressin by an olfactory neuroblastoma causing reversible syndrome of antidiuresis. Am J Med 1986; 81: 911–6
   PubMedGoogle Scholar
• Ng H K, Poon W S, Poon C Y, South J R. Intracranial olfactory neuroblastoma mimicking carcinoma: Report of two cases. Histopathology 1988; 12: 393–403
   PubMedGoogle Scholar
• Llombart B A, Carda C, Peydro-Olaya A, Noguera R, Boix J, Pellin A. Pigmented esthesioneuroblastoma showing dual differentiation following transplantation in nude mice. An immuno-histochemical, electron microscopical, and cytogenetic analysis. Virchows Arch ‘A’ 1989; 414: 199–208
   Google Scholar
• Miser J S, Kinsella T J, Triche T J, et al. Treatment of peripheral neuroepithelioma in children and young adults. J Clin Oncol 1987; 5: 1752–8
   PubMed Web of Science ®Google Scholar
• Miser J S, Kinsella T J, Triche T J, et al. Preliminary results of treatment of Ewing's sarcoma of bone in children and young adults: Six months of intensive combined modality therapy without maintenance. J Clin Oncol 1988; 6: 484–90
   PubMed Web of Science ®Google Scholar
• D'Angio G J. Neuroblastoma overview—1986. Med Pediatr Oncol 1987; 15: 159–62
   PubMedGoogle Scholar